From: Association between β-blocker use and mortality in critically ill patients: a nested cohort study
β-blocker therapy | Oral n (%)a | IV n (%) |
---|---|---|
Metoprolol | 68 (76.4) | 0 |
Atenolol | 23 (25.8) | 0 |
Carvedilol | 1 (1.1) | 0 |
Labetolol | 1 (1.1) | 12 (13.5) |
Sotalol | 1 (1.1) | 0 |